LY-341495: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:LY-341495}} | |||
== | == Overview == | ||
LY-341495 is a | '''LY-341495''' is a potent and selective antagonist of the [[metabotropic glutamate receptor]] (mGluR) subtypes. It is primarily used in research to study the role of these receptors in various neurological processes and disorders. | ||
== | == Chemical Structure == | ||
LY- | [[File:LY-341,495_prodrug.svg|thumb|right|Chemical structure of LY-341495]] | ||
LY-341495 is a bicyclic compound with a unique structure that allows it to selectively bind to mGluR subtypes. Its chemical formula is C<sub>11</sub>H<sub>9</sub>NO<sub>4</sub>, and it is known for its high affinity and specificity. | |||
== | == Mechanism of Action == | ||
LY-341495 functions as an antagonist by binding to the [[glutamate receptor]] sites, thereby inhibiting the action of the neurotransmitter [[glutamate]]. This inhibition can modulate synaptic transmission and has implications for understanding [[neurotransmission]] and [[neuroplasticity]]. | |||
== | == Research Applications == | ||
LY-341495 is extensively used in [[neuroscience]] research to explore the role of mGluRs in various conditions such as [[epilepsy]], [[schizophrenia]], and [[anxiety disorders]]. Its ability to selectively block specific mGluR subtypes makes it a valuable tool for dissecting the complex signaling pathways involved in these disorders. | |||
== | == Pharmacokinetics == | ||
The pharmacokinetic profile of LY-341495 is characterized by its ability to cross the [[blood-brain barrier]], making it effective in central nervous system studies. Its metabolism and excretion pathways are subjects of ongoing research to better understand its potential therapeutic applications. | |||
== Related Pages == | |||
* [[Metabotropic glutamate receptor]] | * [[Metabotropic glutamate receptor]] | ||
* [[Glutamate]] | * [[Glutamate]] | ||
* [[ | * [[Neurotransmitter]] | ||
* [[ | * [[Neuroscience]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Neuroscience]] | [[Category:Neuroscience]] | ||
Latest revision as of 10:57, 15 February 2025
Overview[edit]
LY-341495 is a potent and selective antagonist of the metabotropic glutamate receptor (mGluR) subtypes. It is primarily used in research to study the role of these receptors in various neurological processes and disorders.
Chemical Structure[edit]
LY-341495 is a bicyclic compound with a unique structure that allows it to selectively bind to mGluR subtypes. Its chemical formula is C11H9NO4, and it is known for its high affinity and specificity.
Mechanism of Action[edit]
LY-341495 functions as an antagonist by binding to the glutamate receptor sites, thereby inhibiting the action of the neurotransmitter glutamate. This inhibition can modulate synaptic transmission and has implications for understanding neurotransmission and neuroplasticity.
Research Applications[edit]
LY-341495 is extensively used in neuroscience research to explore the role of mGluRs in various conditions such as epilepsy, schizophrenia, and anxiety disorders. Its ability to selectively block specific mGluR subtypes makes it a valuable tool for dissecting the complex signaling pathways involved in these disorders.
Pharmacokinetics[edit]
The pharmacokinetic profile of LY-341495 is characterized by its ability to cross the blood-brain barrier, making it effective in central nervous system studies. Its metabolism and excretion pathways are subjects of ongoing research to better understand its potential therapeutic applications.
